Navigation Links
LifeNet Health Announces First Bio-Implant with New Preservation Technology
Date:11/9/2009

VIRGINIA BEACH, Va., Nov. 9 /PRNewswire/ -- LifeNet Health, a leading allograft bio-implant company, announces the launch of Vertigraft Cervical Bio-Implant (VG2C) with Preservon® Technology

Preservon® is a new, proprietary glycerol-based preservation solution that allows allograft bio-implants to be stored in a fully hydrated state at ambient temperature. This eliminates the need to freeze or freeze-dry bio-implants, doing away with lengthy thawing and rehydration times in operating rooms. VG2C with Preservon® represents the first machined composite bio-implant allografts delivered to the operating room in a fully hydrated state without the need for frozen storage.

VG2C allograft bio-implants in frozen form have been one of the most widely utilized machined allografts for anterior cervical fusion surgery, with over 200,000 grafts distributed since 2002. This new ambient storage packaging provides greater convenience for the hospital and OR staff and eliminates the need for expensive freezer storage while retaining the proven performance that surgeons have grown to trust for their patients.

Preservon® combined with LifeNet Health's patented Allowash XG process delivers a sterile (SAL of 10(-6)) allograft bio-implant with the full mechanical properties associated with frozen grafts in an ambient storage package.

"This is a leading advancement in our field. Preservon® allograft bio-implants will save valuable OR time and preserve product integrity. It will benefit surgeons, hospitals and most importantly the patients whom we serve. This is part of our mission in saving lives and restoring health," said Rony Thomas, LifeNet Health CEO and President.

Preservon® is one of several process technology platforms that LifeNet Health has developed to enhance the utility and clinical effectiveness of human allograft tissue. LifeNet Health is currently evaluating other applications that can benefit from this break-through technology including skin, cartilage and other cardiovascular tissues.

Since 1995, LifeNet Health has distributed more than two million bio-implants with no incidence of disease transmission linked to tissue screened and processed using LifeNet Health's proprietary Allowash XG® technology. All allograft tissue undergoes a multi-step quality assurance review that exceeds the standards set by both the FDA and American Association of Tissue Banks (AATB).

About LifeNet Health

LifeNet Health, a non-profit global leader in regenerative medicine, is the world's largest provider of bio-implants and organs for transplantation whose mission is saving lives and restoring health by advancing the field of tissue engineering.

For additional information about LifeNet Health, visit www.lifenethealth.org.

SOURCE LifeNet Health


'/>"/>
SOURCE LifeNet Health
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Clarient to Present at Upcoming Healthcare Investor Conferences in New York City
2. Recession Continues to Depress Sales at Allied Healthcare Products
3. McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP
4. Watson to Present at Credit Suisse Healthcare Conference
5. Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results
6. Statement of Americas Specialty Medicines Companies On House Health Care Bill (H.R. 3962)
7. OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy
8. Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation
9. Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the Donut Hole
10. Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox
11. Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
(Date:9/12/2017)... 12, 2017   EcoVadis , the leading platform for environmental, social ... annual edition of its Global CSR Risk and Performance Index. The report ... based on Scorecard Ratings that analyzed nearly 800,000 data points across the ... ... ...
(Date:9/12/2017)... 12, 2017  ValGenesis Inc., the global leader ... pleased to announce the appointment of Dr. ... Board of Directors and Chairman of Advisory Board ... science companies to manage their entire validation lifecycle ... in this process. Furthermore, ValGenesis VLMS enables rigorous ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the ... today its plans to open a flagship location in Covington, LA at 401 N. ... To Go store next to Office Depot in the Holiday Square shopping center. Its ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... ... ... Asante, a nationally recognized health system in southern Oregon, ... health joint venture through an agreement, effective October 1, 2017, to create AccentCare ... company with Asante, delivering clinically integrated care, for the past eight years. This ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... Hair Restoration, has recently contributed a medical article to the newly revamped ... Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit ...
(Date:10/12/2017)... ... , ... Leading pediatric oncology experts at Children’s National Health System ... of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of the ...
Breaking Medicine News(10 mins):